On Tuesday, January 27, the Hadassah Medical Center signed a Memorandum of Understanding with the renowned Institut de Cancérologie Gustave Roussy (IGR) of Villejuif, France, establishing a twinning initiative for collaboration on cancer healing, teaching, and research between Roussy and Hadassah’s Sharett Institute of Oncology.

Participating in the signing ceremony at Hadassah Hospital-Ein Kerem were Hadassah Director General Prof. Shlomo-Mor-Yosef, Prof. Thomas Tursz, Director General of Gustave Roussy, and Prof. Tamar Peretz, head of Sharett. Adding to the excitement of the event was the presence of 20 supporters from France who were in Israel on a mission.

The twinning initiative had been initiated by Dr. Marlène Meimoun-Saffar, President and Founder of the Collège Interculturel de Dialogue des Civilisations, and Raymond Ortman, President and Founder of the Micheline Ortman Contre Le Cancer association. The momentous event came to fruition with the help of Hadassah International Director of Development for Europe Beatrice Birnbaum. Gustave Roussy is a global center of cancer expertise, with 2000 professionals engaged in cancer treatment, teaching, and research; The Sharett Institute of Oncology, named after the former Israeli Prime Minister Moshe Sharett, who died of cancer, is among the centers of excellence at Hadassah.

As part of this historic day, Prof. Peretz highlighted the activities of Hadassah’s Sharett Institute and Prof. Tursz gave a scientific presentation on the activities of his institute. Dr. Marc Wygoda, Director of Hadassah’s Radiation Oncology Unit, also spoke, focusing on the diverse radiation protocols at Sharett.

Prof. Mor-Yosef thanked the initiators of this collaborative venture and all who came to witness the special signing. “We are all here together, showing the kind of solidarity that builds connections without any political connection, the solidarity that is needed to fight a common enemy—cancer.”